Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
AssigneeSanofi-Eventis
InventorsAhmed ABOUABDELLAH, Antonio Almario Garcia, Christian Hoornaert, Adrien Tak Li
Life of this patent
Estimating the term…
Abstract
The invention relates to a compound having general formula (I): Wherein m, R1 and R2 are as defined herein. The invention also relates to the use of the compound in therapeutics. More specifically, the compounds of the invention are inhibitors of the FAAH enzyme, and therefore, can be used for the treatment of various disorders associated with FAAH enzyme, which include in a non-limiting manner, pain, eating disorders, neurological and psychiatric pathologies, among other disorders.
Claims19
A compound of the formula (I):
- wherein
- m represents an integer equal to 2;
- R1 represents a group chosen from phenyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, oxazolyl, triazolyl, imidazolyl, oxadiazolyl, thiadiazolyl, triazolyl, naphthyl, quinolyl, tetrahydroquinolyl, isoquinolyl, tetrahydroisoquinolyl, phthalazinyl, quinazolinyl, quinoxalinyl, cinnolinyl, naphthyridinyl, benzofuryl, dihydrobenzofuryl, benzothienyl, dihydrobenzothienyl, indolyl, benzoxazolyl, benzisoxazolyl, benzothiazolyl, benzisothiazolyl, benzimidazolyl, indazolyl, pyrrolopyridyl, furopyridyl, dihydrofuropyridyl, thienopyridyl, dihydrothienopyridyl, imidazopyridyl, imidazopyrimidinyl, pyrazolopyridyl, oxazolopyridyl, isoxazolopyridyl, thiazolopyridyl or isothiazolopyridyl;
- wherein said group is optionally substituted with one or more groups R3, which may be identical or different, or with a group R4;
- R2 represents a group of formula CHR5CONHR6;
- R3 represents a halogen atom or a hydroxyl, cyano, nitro, C1-6-alkyl, C1-6-alkoxy, C1-6-thioalkyl, C1-6-fluoroalkyl, C1-6-fluoroalkoxy, —O—(C2-3-alkylene)-, —O—(C1-3-alkylene)-O—, C1-6-fluorothioalkyl, C3-7-cycloalkyl, C3-7-cycloalkyl-C1-3-alkylene, piperidyl, benzyloxy, piperazinyl, pyrrolidinyl, morpholinyl, phenyloxy, NR7R8, NHCOR7, NHSO2R7, COR7, CO2R7, CONR7R8, SO2R7 or SO2NR7R8 group;
- R4 represents a group chosen from phenyl, benzofuryl, naphthyl, pyridyl, pyrimidinyl, pyridazinyl, pyrazinyl, triazinyl, oxazolyl, triazolyl, imidazolyl, oxadiazolyl, thiadiazolyl, triazolyl, quinolyl, tetrahydroquinolyl, isoquinolyl, tetrahydroisoquinolyl, phthalazinyl, quinazolinyl, quinoxalinyl, naphthyridinyl, cinnolinyl, benzothienyl, indolyl, benzoxazolyl, benzisoxazolyl, benzothiazolyl, benzisothiazolyl, benzimidazolyl, indazolyl, pyrrolopyridyl, furopyridyl, dihydrofuropyridyl, thienopyridyl, dihydrothienopyridyl, imidazopyridyl, imidazopyrimidinyl, pyrazopyridyl, oxazolopyridyl, isoxazolopyridyl, thiazolopyridyl or isothiazolo-pyridyl;
- wherein said group R4 is optionally substituted with one or more groups R3, which may be identical or different;
- R5 represents a hydrogen atom or a C1-3-alkyl group;
- R6 represents a hydrogen atom or a C1-6-alkyl, C3-7-cycloalkyl or C3-7-cycloalkyl-C1-3-alkylene group;
- and
- R7 and R8 represent, independently of each other, a hydrogen atom, a C1-3-alkyl group or a phenyl group;
- or
- a salt thereof.
A compound, which is 2-(methylamino)-2-oxoethyl 4-nitrophenyl carbonate of formula:
A compound of the formula (Ia):
- wherein
- m represents an integer equal to 2;
- R represents a methyl or ethyl group;
- R1 represents a group chosen from phenyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, oxazolyl, triazolyl, imidazolyl, oxadiazolyl, thiadiazolyl, triazolyl, naphthyl, quinolyl, tetrahydroquinolyl, isoquinolyl, tetrahydroisoquinolyl, phthalazinyl, quinazolinyl, quinoxalinyl, cinnolinyl, naphthyridinyl, benzofuryl, dihydrobenzofuryl, benzothienyl, dihydrobenzothienyl, indolyl, benzoxazolyl, benzisoxazolyl, benzothiazolyl, benzisothiazolyl, benzimidazolyl, indazolyl, pyrrolopyridyl, furopyridyl, dihydrofuropyridyl, thienopyridyl, dihydrothienopyridyl, imidazopyridyl, imidazopyrimidinyl, pyrazolopyridyl, oxazolopyridyl, isoxazolopyridyl, thiazolopyridyl or isothiazolopyridyl;
- wherein said group is optionally substituted with one or more groups R3, which may be identical or different, or with a group R4;
- R3 represents a halogen atom or a hydroxyl, cyano, nitro, C1-6-alkyl, C1-6-alkoxy, C1-6-thioalkyl, C1-6-fluoroalkyl, C1-6-fluoroalkoxy, —O—(C2-3-alkylene)-, —O—(C1-3-alkylene)-O—, C1-6-fluorothioalkyl, C3-7-cycloalkyl, C3-7-cycloalkyl-C1-3-alkylene, piperidyl, benzyloxy, piperazinyl, pyrrolidinyl, morpholinyl, phenyloxy, NR7R8, NHCOR7, NHSO2R7, COR7, CO2R7, CONR7R8, SO2R7 or SO2NR7R8 group;
- R4 represents a group chosen from phenyl, benzofuryl, naphthyl, pyridyl, pyrimidinyl, pyridazinyl, pyrazinyl, triazinyl, oxazolyl, triazolyl, imidazolyl, oxadiazolyl, thiadiazolyl, triazolyl, quinolyl, tetrahydroquinolyl, isoquinolyl, tetrahydroisoquinolyl, phthalazinyl, quinazolinyl, quinoxalinyl, naphthyridinyl, cinnolinyl, benzothienyl, indolyl, benzoxazolyl, benzisoxazolyl, benzothiazolyl, benzisothiazolyl, benzimidazolyl, indazolyl, pyrrolopyridyl, furopyridyl, dihydrofuropyridyl, thienopyridyl, dihydrothienopyridyl, imidazopyridyl, imidazopyrimidinyl, pyrazopyridyl, oxazolopyridyl, isoxazolopyridyl, thiazolopyridyl or isothiazolo-pyridyl;
- wherein said group R4 is optionally substituted with one or more groups R3, which may be identical or different;
- R5 represents a hydrogen atom or a C1-3-alkyl group;
- and
- R7 and R8 represent, independently of each other, a hydrogen atom, a C1-3-alkyl group or a phenyl group.
Dependencies are inferred from the claim text.